Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Insulin-Dependent, 12

Explore clinical trials studying Diabetes Mellitus, Insulin-Dependent, 12. Study availability and eligibility vary by location and protocol.

57 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Insulin-Dependent, 12 trial results

Active, not recruiting

Combination Immunotherapy in Colorectal Cancer

NCT05571293

Conditions
Colonic Diseases, Colorectal Neoplasms, Diabetes Mellitus, Insulin-Dependent, 12, +9 more
Locations
  • Weill Cornell Medicine/New York-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
  • Weill Cornell Medicine/NewYork Presbyterian - Queens Flushing, New York, United States
  • Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States
View Trial Details
Active, not recruiting

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

NCT05608044

Conditions
Colonic Diseases, Colorectal Neoplasms, Diabetes Mellitus, Insulin-Dependent, 12, +11 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Keck School of Medicine of the University of Southern California Los Angeles, California, United States
  • Rocky Mountain Cancer Center - Aurora Aurora, Colorado, United States
View all 65 locations
View Trial Details
Active, not recruiting

A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

NCT04522323

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Fort Myers, Florida, United States
  • Research Site St Louis, Missouri, United States
  • Research Site New York, United States
View all 20 locations
View Trial Details
Active, not recruiting

A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma

NCT05751928

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +12 more
Locations
  • State Institution "Republican Scientific and Practical Center of Oncology and Medical Radiology named after A.I. N.N. Alexandrov" Lesnoy, Belarus
  • Healthcare Institution "Minsk City Clinical Cancer Center" Minsk, Belarus
  • State Institution "Mogilev Regional Oncological Dispensary" Mogilev, Belarus
  • Healthcare Institution "Vitebsk Regional Clinical Oncology Center" Vitebsk, Belarus
View all 36 locations
View Trial Details
Active, not recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

NCT05732805

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +16 more
Locations
  • Healthcare Institution "Bobruisk Interdistrict Oncological Dispensary" Babruysk, Belarus
  • Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus
  • Health care institution "Grodno University Clinic" Grodno, Belarus
  • Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus
View all 63 locations
View Trial Details
Completed

Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease

NCT02046733

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Diabetes Mellitus, Insulin-Dependent, 12, +10 more
Locations
  • Bendigo Hospital Bendigo, Australia
  • Coffs Harbour Health Campus Coffs Harbour, Australia
  • Royal Brisbane and Women's Hospital (QLD) Herston, Australia
  • Royal Hobart Hospital Hobart, Australia
View all 61 locations
View Trial Details
Completed

Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)

NCT04740307

Conditions
Advanced Hepatocellular Carcinoma, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations
  • City of Hope Comprehensive Cancer Center ( Site 0002) Duarte, California, United States
  • Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - GI and Immunology ( Site 0013) Baltimore, Maryland, United States
  • Icahn School of Medicine at Mount Sinai ( Site 0009) New York, United States
  • Oregon Health and Science University ( Site 0006) Portland, Oregon, United States
View all 40 locations
View Trial Details

Related conditions